A detailed history of Sei Investments CO transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 11,321 shares of ANIP stock, worth $695,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,321
Previous 9,727 16.39%
Holding current value
$695,562
Previous $536,000 45.9%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$54.2 - $69.69 $86,394 - $111,085
1,594 Added 16.39%
11,321 $782,000
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $473,899 - $636,437
9,727 New
9,727 $536,000
Q2 2023

Aug 11, 2023

SELL
$37.29 - $53.83 $126,375 - $182,429
-3,389 Reduced 21.24%
12,568 $676,000
Q1 2023

May 12, 2023

BUY
$37.61 - $45.72 $154,163 - $187,406
4,099 Added 34.57%
15,957 $633,000
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $378,270 - $497,443
11,858 New
11,858 $477,000
Q3 2019

Nov 12, 2019

SELL
$64.7 - $85.39 $163,755 - $216,122
-2,531 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$67.77 - $82.2 $2,914 - $3,534
-43 Reduced 1.67%
2,531 $206,000
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $70,669 - $108,772
1,542 Added 149.42%
2,574 $178,000
Q4 2018

Feb 13, 2019

BUY
$41.17 - $56.44 $10,416 - $14,279
253 Added 32.48%
1,032 $55,000
Q3 2018

Nov 08, 2018

SELL
$52.95 - $71.34 $106,270 - $143,179
-2,007 Reduced 72.04%
779 $43,000
Q2 2018

Aug 03, 2018

BUY
$56.38 - $68.08 $30,106 - $36,354
534 Added 23.71%
2,786 $186,000
Q1 2018

May 11, 2018

BUY
$56.98 - $72.41 $46,552 - $59,158
817 Added 56.93%
2,252 $131,000
Q4 2017

Feb 08, 2018

SELL
$53.3 - $74.56 $9,913 - $13,868
-186 Reduced 11.47%
1,435 $93,000
Q3 2017

Nov 06, 2017

BUY
$43.46 - $52.49 $70,448 - $85,086
1,621
1,621 $85,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.07B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.